GSK lines up further divestment opportunities
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline reported a first quarter broadly in line with expectations, and announced two new initiatives "to increase strategic focus and growth", it said. GSK is actively pursuing the sale of two of its iconic soft drink brands, and is setting up a distinct business unit to deal with its established drugs.